{
    "UI_visible_response": "The heparin contamination crisis in 2008 was primarily linked to the contamination of raw heparin stock imported from mainland China. It was reported that the contaminant found was \"likely made in China from animal cartilage, chemically altered to act like heparin\"7. This led to major recalls of heparin, a substance widely used as an injectable anticoagulant10. The crisis highlighted issues with the identification of contaminated and/or counterfeited imported pharmaceutical products, prompting increased FDA enforcement and policy changes regarding drug substances imported from other countries6. While the contamination originated in China, the crisis also exposed weaknesses in the global supply chain and regulatory oversight, leading to significant responses from the FDA to protect public health2.",
    "traffic_visible_response": "The heparin contamination crisis in 2008 was primarily linked to the contamination of raw heparin stock imported from mainland China. It was reported that the contaminant found was \"likely made in China from animal cartilage, chemically altered to act like heparin\" [[7]]. This led to major recalls of heparin, a substance widely used as an injectable anticoagulant [[10]]. The crisis highlighted issues with the identification of contaminated and/or counterfeited imported pharmaceutical products, prompting increased FDA enforcement and policy changes regarding drug substances imported from other countries [[6]]. While the contamination originated in China, the crisis also exposed weaknesses in the global supply chain and regulatory oversight, leading to significant responses from the FDA to protect public health [[2]].",
    "block_type": "REG",
    "search_status": "search_completed",
    "indicators": "not_filtered"
}